XML 85 R25.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Insider Trading Arrangements | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2024 shares | Jun. 30, 2024 shares
Trading Arrangements, by Individual |  |
Material Terms of Trading Arrangement |  | During the three months ended June 30, 2024, the Company’s six section 16 officers adopted written plan for the purchase or sale of Company securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). These plans were adopted on June 28, 2024, and are subject to a 90-day “cool off” period before any trades may be conducted under such plans.
Name | Titles | Action Taken | Type of Trading | Nature of Trading | Expiration Date | Aggregate Number of Securities
Christophe Arbet-Engels | Chief Medical Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 8/1/2025 | (i) 572,917 shares of common stock subject to employee stock options and (ii) Indeterminable (2).
Mark Baldry | Chief Commercial Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 10/1/2025 | Indeterminable (1)
Mary DiBiase | Chief Operating Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 10/1/2025 | Indeterminable (1)
Adam Mostafa | Chief Financial Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 10/1/2025 | Indeterminable (2)
Paula Ragan | President and Chief Executive Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 10/1/2025 | (i) 313,794 shares of common stock subject to long, restricted and control stock and (ii) Indeterminable (1)
Arthur Taveras | Chief Scientific Officer | Adoption (June 28, 2024) | Rule 10b5-1 trading arrangement | Sale | 10/1/2025 | Indeterminable (1)
(1) The number of shares that will be sold in accordance with this trading arrangement is indeterminable at the time of the filing of this Quarterly Report on Form 10-Q for the period ended June 30, 2024. Upon vesting of PRSUs, a sell-to-cover trade may occur or the Company may withhold shares in order to satisfy any applicable tax withholding obligations on behalf of the employee. The number of shares sold in the sell-to-cover will vary based on the market price of the Company’s common stock at the time of settlement. (2) The number of shares that will be sold in accordance with this trading arrangement is indeterminable at the time of the filing of this Quarterly Report on Form 10-Q for the period ended June 30, 2024. Upon vesting of PRSUs, a sell-to-cover trade may occur or the Company may withhold shares in order to satisfy any applicable tax withholding obligations on behalf of the employee. The number of shares sold in the sell-to-cover will vary based on the market price of the Company’s common stock at the time of settlement. Any remaining shares held by the seller after the sell-to-cover may be sold pursuant to the terms of this trading arrangement. .
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Christophe Arbet-Engels [Member] |  |
Trading Arrangements, by Individual |  |
Name | Christophe Arbet-Engels |
Title | Chief Medical Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 399 days |
Aggregate Available | 572,917 | 572,917
Mark Baldry [Member] |  |
Trading Arrangements, by Individual |  |
Name | Mark Baldry |
Title | Chief Commercial Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 460 days |
Mary DiBiase [Member] |  |
Trading Arrangements, by Individual |  |
Name | Mary DiBiase |
Title | Chief Operating Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 460 days |
Adam Mostafa [Member] |  |
Trading Arrangements, by Individual |  |
Name | Adam Mostafa |
Title | Chief Financial Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 460 days |
Paula Ragan [Member] |  |
Trading Arrangements, by Individual |  |
Name | Paula Ragan |
Title | President and Chief Executive Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 460 days |
Aggregate Available | 313,794 | 313,794
Art Taveras [Member] |  |
Trading Arrangements, by Individual |  |
Name | Arthur Taveras |
Title | Chief Scientific Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 28, 2024 |
Arrangement Duration | 460 days |

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_MtrlTermsOfTrdArrTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TradingArrByIndTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph B + Details
Name: | ecd_TrdArrAdoptionDate
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph C + Details
Name: | ecd_TrdArrDuration
Namespace Prefix: | ecd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndTitle
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph D + Details
Name: | ecd_TrdArrSecuritiesAggAvailAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=xfor_ChristopheArbetEngelsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=xfor_MarkBaldryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=xfor_MaryDiBiaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=xfor_AdamMostafaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=xfor_PaulaRaganMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=xfor_ArtTaverasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |